Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Trial of Rituximab for Pediatric Opsoclonus-Myoclonus Syndrome

NCT00244361 is registered in ClinicalTrials.gov with National Pediatric Neuroinflammation Organization, Inc. as lead sponsor.

NCT NCT00244361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00244361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Trial of Rituximab for Pediatric Opsoclonus-Myoclonus Syndrome
Lead sponsor
National Pediatric Neuroinflammation Organization, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2005
Completion date
December 31, 2007
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia, myoclonus, opsoclonus, opsoclonus-myoclonus syndrome